Global Cardiac POC Testing Devices and Kits Market Size By Type (Cardiac POC Testing Analyzer, Cardiac POC Test Kits), By Application (Hospitals, Clinic), By Region, And Segment Forecasts, 2023 to 203...

The Global Cardiac POC (Point-of-Care) Testing Devices and Kits Market was valued at USD 2.1 billion in 2023 and is projected to reach USD 4.3 billion by 2031, expanding at a CAGR of 9.3% during the forecast period from 2023 to 2031. This robust growth is driven by the rising incidence of cardiovascular diseases (CVDs), increasing demand for rapid diagnostic solutions, and the technological advancements in portable testing devices. Cardiac POC testing enables timely diagnosis and management of acute cardiac events, significantly improving clinical outcomes, especially in emergency and remote settings.

Drivers:

1. Rising Prevalence of Cardiovascular Diseases:

Heart diseases remain the leading cause of mortality globally. The escalating prevalence of conditions such as myocardial infarction, heart failure, and arrhythmias is generating substantial demand for POC diagnostic tools that can deliver quick and accurate cardiac biomarker results.

2. Technological Innovations in POC Devices:

Advancements in biosensor technology, microfluidics, and data connectivity have led to the development of compact, accurate, and user-friendly cardiac testing kits. Integration with digital health platforms enables remote monitoring and decision-making, bolstering market growth.

3. Demand for Decentralized and Rapid Diagnostics:

Hospitals, ambulatory care centers, and even home healthcare providers increasingly prefer POC cardiac testing to enable faster diagnosis and treatment initiation. This trend is further supported by healthcare policies promoting preventive care and early intervention.

Restraints:

1. Regulatory and Reimbursement Challenges:

Stringent regulatory frameworks for diagnostic devices and inconsistent reimbursement policies across regions may restrict market access, particularly for novel POC products.

2. High Cost of Advanced POC Kits:

Although highly effective, many cutting-edge POC cardiac diagnostic devices come with high acquisition and maintenance costs, limiting adoption in cost-sensitive and under-resourced settings.

Opportunity:

1. Expanding Applications in Home Healthcare and Remote Monitoring:

With the global shift toward home-based care and telemedicine, the demand for user-friendly and connected cardiac POC devices is rising rapidly. Innovations tailored for non-specialist users and remote environments offer immense growth potential.

2. Growth in Emerging Economies:

Healthcare infrastructure expansion and growing awareness of cardiovascular health in Asia-Pacific, Latin America, and Africa are opening new frontiers for market expansion. Governments and private entities are investing in mobile health and decentralized diagnostic capabilities.

Market by System Type Insights:

The market is segmented into Handheld Cardiac POC Devices and Benchtop Cardiac POC Devices. In 2023, the Handheld Devices segment dominated the market due to its portability, ease of use, and application in both clinical and non-clinical environments. Benchtop devices, however, maintain a strong presence in hospital emergency rooms and ICUs for higher-throughput testing.

Market by End-use Insights:

Hospitals and Clinics accounted for the largest share in 2023, driven by the high patient footfall and need for rapid diagnostics in acute care settings. The Homecare Settings segment is expected to grow at the highest CAGR during the forecast period, thanks to technological innovations that allow patients to monitor cardiac health from the comfort of their homes.

Market by Regional Insights:

North America led the market in 2023, supported by robust healthcare infrastructure, high awareness, and strong adoption of POC technologies. Meanwhile, Asia-Pacific is projected to witness the fastest growth, propelled by increasing CVD incidence, healthcare reforms, and the adoption of digital health tools in countries like China and India.

Competitive Scenario:

Leading players in the Global Cardiac POC Testing Devices and Kits Market include:

Abbott Laboratories

F. Hoffmann-La Roche Ltd

Siemens Healthineers

QuidelOrtho Corporation

Radiometer Medical ApS

BioMérieux SA

Nova Biomedical

LumiraDx

Beckman Coulter, Inc.

These companies are focusing on product innovation, strategic partnerships, and geographical expansion. For instance:

In 2024, Abbott launched a next-gen portable cardiac troponin test with Bluetooth connectivity for real-time remote reporting.

Roche expanded its cobas e POC line with enhanced NT-proBNP testing capabilities in 2023.

LumiraDx collaborated with global NGOs in 2025 to pilot cardiac POC kits in rural health centers across Africa.

Scope of Work – Global Cardiac POC Testing Devices and Kits Market

Key Market Developments:

2024: Siemens Healthineers released an upgraded version of its Stratus CS Analyzer with enhanced portability and AI-based interpretation algorithms.

2023: BioMérieux partnered with a leading telehealth provider to integrate its cardiac POC tests into virtual emergency consultation workflows.

2025: Radiometer launched a multi-analyte POC device with cloud-based data logging for cardiac event trend monitoring in community care setups.

FAQs:

1. What is the current market size of the Global Cardiac POC Testing Devices and Kits Market?

The market was valued at USD 2.1 billion in 2023.

2. What is the major growth driver of the Global Cardiac POC Testing Devices and Kits Market?

The major driver is the rising prevalence of cardiovascular diseases and demand for rapid diagnostics.

3. Which is the largest region during the forecast period in the Global Cardiac POC Testing Devices and Kits Market?

North America holds the largest market share due to advanced healthcare infrastructure and high adoption of POC technologies.

4. Which segment accounted for the largest market share in the Global Cardiac POC Testing Devices and Kits Market?

Hospitals and Clinics segment accounted for the largest share in 2023.

5. Who are the key market players in the Global Cardiac POC Testing Devices and Kits Market?

Key players include Abbott, Roche, Siemens Healthineers, QuidelOrtho, Radiometer Medical, BioMérieux, Nova Biomedical, and LumiraDx.